Search details
1.
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis.
Mol Psychiatry
; 28(7): 2872-2877, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37131073
2.
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
Mol Psychiatry
; 27(1): 34-37, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34140635
3.
Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs.
J Immunol
; 199(7): 2261-2269, 2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28835460
4.
Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity.
J Immunol
; 197(6): 2157-66, 2016 09 15.
Article
in English
| MEDLINE | ID: mdl-27511730
5.
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.
Open Forum Infect Dis
; 11(1): ofad641, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38179103
6.
Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19.
Lancet Microbe
; 2(4): e138, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33817676
7.
Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity.
J Exp Med
; 209(8): 1419-26, 2012 Jul 30.
Article
in English
| MEDLINE | ID: mdl-22802351
8.
Deregulated type I IFN response in TREX1-associated familial chilblain lupus.
J Invest Dermatol
; 134(5): 1456-1459, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24270665
Results
1 -
8
de 8
1
Next >
>>